British Journal of Cancer - Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics Skip to main content Thank you for visiting nature ...

Squamous-cell carcinoma is one of the most common cancers in humans. Most cases are localized and treatable; the small percentage that recur or spread can be fatal. Immunocompromised patients are a ...

The approval was based on data from an open-label study (ClinicalTrials.gov Identifier: NCT03212404) that evaluated cosibelimab, a programmed death ligand-1 (PD-L1) blocking antibody, in patients ...

Ficerafusp alfa with pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: Updated results from an expansion cohort of an open-label, multicenter, phase 1/1b ...

Exfoliative cytology: During this test, a doctor will scrape a sample from the person’s mouth and then stain the sample with dye. ... Schiff BA. (2022). Oral squamous cell carcinoma. https: ...

Squamous cell carcinoma is the second most common type of skin cancer. It begins in the outermost layer of the skin, known as the epidermis. Share on Pinterest Gravity Images/Getty Images Squamous ...

Background: HPV-negative head and neck squamous cell carcinoma (HNSCC) is an aggressive disease characterized by high recurrence, metastasis (R/M), and resistance to standard treatments. While anti–PD ...